Literature DB >> 6490

Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.

J L Feldmann, M J Becker, H Moutsopoulos, K Fye, M Blackman, W V Epstein, N Talal.   

Abstract

Antibody-dependent cell-mediated cytotoxicity mediated by peripheral blood lymphocytes was studied in patients with systemic lupus erythematosus, polyarteritis nodosa. Sjogren's syndrome, and rheumatoid arthritis. The target cells were chicken erythrocytes coated with rabbit anti-chicken erythrocyte antibody. Antibody-dependent cell-mediated cytotoxic activity was normal in Sjogren's syndrome and rheumatoid arthritis but significantly decreased (P is less than 0.001) in active systemic lupus erythematosus and in two patients with polyarteritis nodosa. A partial regeneration of antibody-dependent cell-mediated cytotoxic activity was obtained by treatment with pronase and DNase followed by overnight incubation. Sera from patients with systemic lupus erythematosus inhibited antibody-dependent cell-mediated cytotoxic activity of normal lymphocytes. The inhibitory activity was studied by specific immunoadsorption and sucrose density geadient ultracentrifugation. Removal of IgG but not IgM greatly reduced inhibition. Inhibitory factors were present in 7S and heavier fractions containing IgG. Five systemic lupus erythematosus patients were studied serially to determine if improvement in clinical status could be correlated with a decrease in serum inhibitory factors as studied by inhibition of normal antibody-dependent cell-mediated cytotoxicity. Indeed, a greater serum inhibitory capacity was found in each patient during periods of greater disease activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 6490      PMCID: PMC333168          DOI: 10.1172/JCI108447

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Antibody in the induction and inhibition of lymphocyte cytotoxicity.

Authors:  I C MacLennan
Journal:  Transplant Rev       Date:  1972

2.  Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells.

Authors:  P Perlmann; H Perlmann; H Wigzell
Journal:  Transplant Rev       Date:  1972

3.  Competition for receptors for immunoglobulin on cytotoxic lymphocytes.

Authors:  I C MacLennan
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

4.  Antibody-induced in vitro lymphocyte cytotoxicity in Hashimoto thyroiditis.

Authors:  J Wasserman; L V von Stedingk; P Perlmann; J Jonsson
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

5.  Lymphocyte-dependent antibody-mediated cytotoxicity in Hashimoto thyroiditis.

Authors:  E A Calder; W J Penhale; D McLeman; E W Barnes; W J Irvine
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

6.  Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity.

Authors:  E Kedar; M Otiz de Landazuri; J L Fahey
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

7.  IgM and IgG antibodies to DNA, RNA, and DNA:RNA in systemic lupus erythematosus.

Authors:  N Talal; R Pillarisetty
Journal:  Clin Immunol Immunopathol       Date:  1975-05

8.  Studies of human sera with cytotoxic activity.

Authors:  R C Williams; J D Emmons; E J Yunis
Journal:  J Clin Invest       Date:  1971-07       Impact factor: 14.808

9.  Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker.

Authors:  C O'Toole; V Stejskal; P Perlmann; M Karlsson
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

10.  A new sensitive assay for antibody against cell surface antigens based on inhibition of cell-dependent antibody-mediated cytotoxicity. I. Specificity and sensitivity.

Authors:  P Halloran; V Schirrmacher; H Festenstein
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

2.  K-lymphocytes (killer-cells) in Crohn's disease and acute virus B-hepatitis.

Authors:  R Eckhardt; P Kloos; M P Dierich; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

3.  Behaviour of effector cells, synovial fluids, and sera from rheumatoid arthritis patients in antibody-dependent cell-mediated cytotoxicity.

Authors:  L A Cooke; F C Hay; R Perumal
Journal:  Ann Rheum Dis       Date:  1979-06       Impact factor: 19.103

4.  Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.

Authors:  S Kumagai; A D Steinberg; I Green
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

5.  T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.

Authors:  K Okudaira; R P Searles; K Tanimoto; Y Horiuchi; R C Williams
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

Review 6.  The role of immunotherapy in type I diabetes mellitus.

Authors:  M E Geffner; B M Lippe
Journal:  West J Med       Date:  1987-03

7.  Immunological studies in patients with rheumatoid arthritis receiving azathioprine and myocrisin in combination.

Authors:  P Lewis; B L Hazleman; J R Park; D Y Bulgen; D Franks; C Hurd; D L Brown
Journal:  Clin Rheumatol       Date:  1982-09       Impact factor: 2.980

8.  Antibody-dependent killer-cell function in insulin-dependent diabetes mellitus.

Authors:  H Ludwig; G Schernthaner; D Kraft; O Scheiner; W R Mayr
Journal:  J Endocrinol Invest       Date:  1980 Jan-Mar       Impact factor: 4.256

9.  Selective decrease in antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus and progressive systemic sclerosis.

Authors:  S M Cooper; B Harding; G R Mirick; J Schneider; F P Quismorio; G J Friou
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

10.  Natural cytotoxicity in systemic lupus erythematosus: mechanisms of suppression by inhibitory serum factors.

Authors:  W L Sibbitt; C J Froelich; A D Bankhurst
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.